Double marker and quadruple marker tests are recommended for pregnant women. These blood tests help identify the possibility of chromosomal abnormalities and developmental defects in the unborn child. The marker tests serve as crucial tools for risk assessment, and guide further testing and interventions as necessary.
There are several tests that are widely carried out during pregnancy to check maternal and foetal well-being. Quadruple and dual marker tests are commonly done, for instance, to detect congenital and genetic disorders in the foetus. Marker tests help check if the foetus can potentially have Down’s syndrome or other defects that may impair their physiological and psychological development.
The purpose of dual and quadruple marker tests is to screen for potential birth defects and genetic abnormalities in the foetus. These tests analyse specific substances present in the blood of the mother in order to assess the risk of varied conditions.
Double Marker Test: This test is conducted during the first trimester. It measures free beta-hCG (human chorionic gonadotropin) and PAPP-A (pregnancy-associated plasma protein A). This helps determine if there is a higher risk of chromosomal conditions such as Down’s syndrome.
Quadruple Marker Test: This test is generally performed in the second trimester. It measures AFP (alpha-fetoprotein), Beta hCG (human chorionic gonadotropin), Inhibin-A and Estriol. Healthcare professionals use these biochemical markers, combined with maternal age, to identify pregnancies that may require closer monitoring.
Both test for chromosomal abnormalities like Down syndrome. However, the Quadruple Marker Test also screens for neural tube defects like spina bifida, which provides a better picture of the baby's overall health and well-being.
The timing of quadruple and dual marker tests in pregnancy is extremely important.
• The double marker test is usually performed during the first trimester, between 10 and 14 weeks of pregnancy.
• The quadruple marker test is generally conducted during the second trimester, ideally between 16 and 20 weeks.
The procedure for these tests just involves a blood draw from the mother, making them relatively low-risk.
• Risk Evaluation: Healthcare professionals use specific biochemical markers found in the mother’s blood to evaluate the likelihood of certain genetic conditions or congenital abnormalities in the developing foetus. These markers, when analysed in combination with other factors such as maternal age and medical history, help provide an estimated level of risk. This early assessment plays a crucial role in identifying pregnancies that may require closer monitoring or additional medical attention.
• Direction for Additional Testing: If the test results indicate a higher risk, doctors may recommend further diagnostic procedures to gain more clarity. These may include non-invasive techniques like NIPT as well as invasive tests like amniocentesis or chorionic villus sampling. Such follow-up tests can either confirm or rule out potential conditions, facilitating more accurate medical evaluation and planning.
For many expecting parents, dual and quadruple marker tests offer a sense of reassurance by providing early insights into the baby’s health. Even in cases where results indicate a higher probability of complications, having this information in advance allows families to prepare emotionally, seek appropriate medical guidance, and make well-informed decisions regarding the pregnancy and the child’s future care. Information regarding the quadruple marker test price and double marker test details can be found on the web.